Sarepta Therapeutics, Inc. (SRPT)

Healthcare · Biotechnology · NASDAQ

Sarepta Therapeutics, Inc. (SRPT) is a Healthcare company in the Biotechnology industry. It has a market capitalization of $2.20B, a trailing price-to-earnings ratio of 231.2 and a free-cash-flow yield of -15.5%. Over the most recent reported fiscal year, revenue grew 15.6%.

Market cap	$2.20B
Trailing P/E	231.2
FCF yield	-15.5%
Revenue growth (YoY)	+15.6%
EPS growth (YoY)	-238.5%
FCF/share growth (YoY)	—
Exchange	NASDAQ
Sector	Healthcare
Industry	Biotechnology

Explore live SRPT data on Nama Insights →

Recent Congressional trades

Sarepta Therapeutics, Inc. trades disclosed by members of the US House and Senate under the STOCK Act. See the full Congress trades board →

Member	Chamber	Trade	Amount	Disclosed
Gilbert Cisneros	House	Sell	$1,001 - $15,000	May 6, 2025
Josh Gottheimer	House	Buy	$1,001 - $15,000	Aug 21, 2023